GREE vs RNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

GREE

56.8
AI Score
VS
GREE Wins

RNA

55.2
AI Score

Investment Advisor Scores

GREE

57score
Recommendation
HOLD

RNA

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GREE RNA Winner
Revenue 20.83M 19.64M GREE
Net Income -4.58M -16.63M GREE
Net Margin -22.0% -84.7% GREE
Operating Income -4.55M -17.28M GREE
ROE 9.1% -7.1% GREE
ROA -9.9% -5.7% RNA
Total Assets 46.12M 292.36M RNA
Cash 7.05M 267.85M RNA
Current Ratio 0.50 13.04 RNA

Relative Price Performance (Last 90 Days)

GREE 1M: +78.6% · 3M: +118.5% RNA 1M: -17.0% · 3M: -15.6%

Current Technical Phase

GREE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.1% over 20 days), RSI 72

RSI (14): 71.6 · Price: $2.84

RNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 37

RSI (14): 37.0 · Price: $11.33

Fundamentals Snapshot

Metric GREE RNA
Market Cap
Forward P/E 0.0 -1.9
Trailing P/E 6.5
Revenue (TTM)
Revenue Growth 0.1% 11.5%
Gross Margin 0.1% -0.3%
Operating Margin -0.1% -0.9%
EPS 0.45 -5.02
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GREE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.